ICH - International Conference on Harmonization

ICH is a a joint initiative involving both regulators and industry as equal partners in the scientific and technical discussions of the testing procedures which are required to ensure and assess the safety, quality and efficacy of medicines.

The focus of ICH has been on the technical requirements for medicinal products containing new drugs. The vast majority of those new drugs and medicines are developed in Western Europe, Japan and the United States of America and therefore, when ICH was established, it was agreed that its scope would be confined to registration in those three regions. Canada is an observer to ICH and where possible, applies their standards.
For more information related to ICH, please consult their website at:

International Conference on Harmonization